Combination therapies utilizing neoepitope-targeted vaccines Karin L. LeeJeffrey SchlomDuane H. Hamilton Review Open access 08 October 2020 Pages: 875 - 885
Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma Katharina LeuchteElena StaibHans Anton Schlößer Original Article Open access 02 October 2020 Pages: 893 - 907
Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity Rosmely HernandezKevin H. ToomerThomas R. Malek Original Article 10 October 2020 Pages: 909 - 921
A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment Zuzana SaidakSimon SoudetAntoine Galmiche Original Article 15 October 2020 Pages: 923 - 933
Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review Aasir M. SulimanShaza A. BekNabil E. Omar Original Article Open access 17 October 2020 Pages: 935 - 944
Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial Hiroto Matsui MatsuiShoichi HazamaHiroaki Nagano Original Article 19 October 2020 Pages: 945 - 957
Correction to: Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial Hiroto MatsuiShoichi HazamaHiroaki Nagano Correction 05 January 2021 Pages: 959 - 959
Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC) Yeseul KimElena VagiaYoung Kwang Chae Original Article 21 October 2020 Pages: 961 - 965
An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma Yifei DaiWeijie QiangDong Wang Original Article 21 October 2020 Pages: 967 - 979
Notch signaling defects in NK cells in patients with cancer Gulnur K. ZakiryanovaElena KustovaMichael R. Shurin Original Article 21 October 2020 Pages: 981 - 988
Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide Ayman J. OweidaAdam C. MuellerSana D. Karam Original Article 23 October 2020 Pages: 989 - 1000
Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers Wei ZhangJunping ShiQiangLi Original Article 23 October 2020 Pages: 1001 - 1014
OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway Xin PangSha-sha WangYa-ling Tang Original Article 26 October 2020 Pages: 1015 - 1029
Merkel cell carcinoma in Latin America: a contribution from an expanded access program for avelumab to address issues from experts’ recommendations Rodrigo Ramella MunhozFederico CayolGabriela Cinat Original Article 26 October 2020 Pages: 1031 - 1036
Retinoblastoma cell-derived Twist protein promotes regulatory T cell development Ruishi ZhangYan-Nan SongGuohui Nie Original Article 27 October 2020 Pages: 1037 - 1048
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model Shiwen PengMarietta TanT.-C. Wu Original Article 27 October 2020 Pages: 1049 - 1062
Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancer Koji TeramotoTomoyuki IgarashiYataro Daigo Original Article 28 October 2020 Pages: 1063 - 1074
Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors Gun-Young JangYoung Seob KimYeong-Min Park Original Article 28 October 2020 Pages: 1075 - 1088
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors Johanna WinterMax M. LendersNikolaus B. Wagner Original Article 28 October 2020 Pages: 1089 - 1099
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity Simone PuntShruti MaluPatrick Hwu Original Article Open access 29 October 2020 Pages: 1101 - 1113
Reduction of derived neutrophil-to-lymphocyte ratio after four weeks predicts the outcome of patients receiving second-line chemotherapy for metastatic colorectal cancer Giuseppe Antonio CollocaAntonella VenturinoDomenico Guarneri Original Article 29 October 2020 Pages: 1115 - 1125
Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm Nicki PanoskaltsisNeil E. McCarthyStella C. Knight Original Article 08 October 2020 Pages: 1127 - 1142
Patients with gastrointestinal irritability after TGN1412-induced cytokine storm displayed selective expansion of gut-homing αβ and γδT cells Neil E. McCarthyAndrew J. StaggNicki Panoskaltsis Original Article 13 October 2020 Pages: 1143 - 1153
Myelopoiesis of acute inflammation: lessons from TGN1412-induced cytokine storm Nicki PanoskaltsisNeil E. McCarthyStella C. Knight Research Report 30 August 2020 Pages: 1155 - 1160
Selective CD47 targeting with a bispecific antibody Walter FerlinKrzysztof MasternakLimin Shang Letter to the Editors 02 January 2021 Pages: 1161 - 1162
Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy Lukas MarcelisAsier AntoranzThomas Tousseyn Correction 17 February 2021 Pages: 1163 - 1163